Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2023

02.06.2023 | Oncology

Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis

verfasst von: Frances Wu, Anne Marie Lane, Monica M. Oxenreiter, Evangelos S. Gragoudas, Ivana K. Kim

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Small choroidal melanocytic lesions have a low rate of metastasis and can be reasonably managed with surveillance until they demonstrate evidence of growth or clinical risk factors for melanoma. However, even choroidal nevi are not stationary, with many exhibiting slow growth over time. We sought to quantify the growth rates of indeterminate choroidal lesions that were initially observed prior to a clinical diagnosis of melanoma.

Methods

A single-center retrospective study was performed of patients diagnosed with choroidal melanoma based upon clinical characteristics who were initially followed for indeterminate lesions over at least 6 months. Subjects were included if they had a minimum of two B-scan ultrasound measurements prior to the visit at which melanoma was diagnosed. Demographic and tumor characteristics were collected from the medical record. Growth rates were calculated as the change in lesion thickness in mm per month and were recorded at 6-month intervals; ultrasound measurements less than 1 month apart were excluded. The characteristics of indeterminate lesions with faster versus slower growth rates prior to melanoma diagnosis were compared.

Results

Fifty-four patients met inclusion criteria. The mean age at melanoma diagnosis was 67.4 years, and 53.7% were female. Subjects had a median of four B-scan ultrasound measurements prior to melanoma diagnosis (range 2–19) and were followed for a median of 40.6 months (range 9.9–138.0 months). The mean lesion thickness was 1.4 mm (range 0.5–2.2 mm) at presentation, and increased to 2.3 mm (range 1.5–5.7 mm) at melanoma diagnosis. The mean growth rate did not exceed 0.021 mm/month (95% CI: 0.004–0.039; equivalent to 0.25 mm/year) for indeterminate lesions, but increased to 0.057 mm/month (95% CI: 0.043–0.071 mm/month; equivalent to 0.68 mm/year) at the time of melanoma diagnosis. Rapidly growing lesions had a greater tumor thickness and shorter duration of observation at the time of melanoma diagnosis.

Conclusion

For most indeterminate choroidal lesions eventually diagnosed as melanoma, the lesion thickness was relatively stable for a period of time, then rose significantly between the penultimate visit and the final visit. These findings confirm the recommendation for continued monitoring of suspicious choroidal lesions, as the growth rate may accelerate just prior to melanoma diagnosis. Lesions with a mean growth rate of up to 0.25 mm/year were observed, whereas lesions clinically determined to have transformed into melanoma demonstrated a mean growth rate of 0.68 mm/year. These values provide a baseline for future studies and potential therapies directed at stabilizing or reducing the growth of indeterminate choroidal lesions or small choroidal melanomas. Limitations of this study include its retrospective nature and reliance on clinical diagnostic criteria.
Literatur
1.
Zurück zum Zitat Murray TG, Sobrin L (2006) The case for observational management of suspected small choroidal melanoma. Arch Ophthalmol Chic Ill 1960 124(9):1342–1344CrossRef Murray TG, Sobrin L (2006) The case for observational management of suspected small choroidal melanoma. Arch Ophthalmol Chic Ill 1960 124(9):1342–1344CrossRef
2.
Zurück zum Zitat Shields JA (2006) Treating some small melanocytic choroidal lesions without waiting for growth. Arch Ophthalmol Chic Ill 1960 124(9):1344–1346CrossRef Shields JA (2006) Treating some small melanocytic choroidal lesions without waiting for growth. Arch Ophthalmol Chic Ill 1960 124(9):1344–1346CrossRef
3.
Zurück zum Zitat Gass JD (1985) Comparison of uveal melanoma growth rates with mitotic index and mortality. Arch Ophthalmol Chic Ill 1960 103(7):924–931CrossRef Gass JD (1985) Comparison of uveal melanoma growth rates with mitotic index and mortality. Arch Ophthalmol Chic Ill 1960 103(7):924–931CrossRef
4.
Zurück zum Zitat (1997) Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 115(7):886–93 (1997) Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 115(7):886–93
5.
Zurück zum Zitat Jouhi S, Jager MJ, de Geus SJR et al (2019) The small fatal choroidal melanoma study. A survey by the European Ophthalmic Oncology Group. Am J Ophthalmol 202:100–108CrossRefPubMed Jouhi S, Jager MJ, de Geus SJR et al (2019) The small fatal choroidal melanoma study. A survey by the European Ophthalmic Oncology Group. Am J Ophthalmol 202:100–108CrossRefPubMed
6.
Zurück zum Zitat Lane AM, Egan KM, Kim IK, Gragoudas ES (2010) Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol Chic Ill 1960 128(8):996–1000CrossRef Lane AM, Egan KM, Kim IK, Gragoudas ES (2010) Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol Chic Ill 1960 128(8):996–1000CrossRef
7.
Zurück zum Zitat Augsburger JJ, Schroeder RP, Territo C et al (1989) Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol 73(11):911–917CrossRefPubMedPubMedCentral Augsburger JJ, Schroeder RP, Territo C et al (1989) Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol 73(11):911–917CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Sobrin L, Schiffman JC, Markoe AM, Murray TG (2005) Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Ophthalmology 112(10):1777–1783CrossRefPubMed Sobrin L, Schiffman JC, Markoe AM, Murray TG (2005) Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Ophthalmology 112(10):1777–1783CrossRefPubMed
11.
Zurück zum Zitat Shields CL, Dalvin LA, Yu MD et al (2019) Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: the 2019 Wendell L. Hughes Lecture. Retina Phila Pa 39(10):1852–1860CrossRef Shields CL, Dalvin LA, Yu MD et al (2019) Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: the 2019 Wendell L. Hughes Lecture. Retina Phila Pa 39(10):1852–1860CrossRef
12.
Zurück zum Zitat Elner VM, Flint A, Vine AK (2004) Histopathology of documented growth in small melanocytic choroidal tumors. Arch Ophthalmol Chic Ill 1960 122(12):1876–1878CrossRef Elner VM, Flint A, Vine AK (2004) Histopathology of documented growth in small melanocytic choroidal tumors. Arch Ophthalmol Chic Ill 1960 122(12):1876–1878CrossRef
13.
Zurück zum Zitat Mruthyunjaya P, Schefler AC, Kim IK et al (2020) A phase 1b/2 open-label clinical trial to evaluate the safety and efficacy of AU-011 for the treatment of choroidal melanoma. Invest Ophthalmol Vis Sci 61(7):4025–4025 Mruthyunjaya P, Schefler AC, Kim IK et al (2020) A phase 1b/2 open-label clinical trial to evaluate the safety and efficacy of AU-011 for the treatment of choroidal melanoma. Invest Ophthalmol Vis Sci 61(7):4025–4025
14.
15.
Zurück zum Zitat Shields CL, Dalvin LA, Ancona-Lezama D et al (2019) Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina Phila Pa 39(10):1840–1851CrossRef Shields CL, Dalvin LA, Ancona-Lezama D et al (2019) Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina Phila Pa 39(10):1840–1851CrossRef
16.
Zurück zum Zitat Mashayekhi A, Siu S, Shields CL, Shields JA (2011) Slow enlargement of choroidal nevi: a long-term follow-up study. Ophthalmology 118(2):382–388CrossRefPubMed Mashayekhi A, Siu S, Shields CL, Shields JA (2011) Slow enlargement of choroidal nevi: a long-term follow-up study. Ophthalmology 118(2):382–388CrossRefPubMed
17.
18.
Zurück zum Zitat Augsburger JJ, Gonder JR, Amsel J et al (1984) Growth rates and doubling times of posterior uveal melanomas. Ophthalmology 91(12):1709–1715CrossRefPubMed Augsburger JJ, Gonder JR, Amsel J et al (1984) Growth rates and doubling times of posterior uveal melanomas. Ophthalmology 91(12):1709–1715CrossRefPubMed
20.
Zurück zum Zitat Char DH, Kroll S, Phillips TL (1997) Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol Chic Ill 1960 115(8):1014–1018CrossRef Char DH, Kroll S, Phillips TL (1997) Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol Chic Ill 1960 115(8):1014–1018CrossRef
21.
Zurück zum Zitat Friberg TR, Fineberg E, McQuaig S (1983) Extremely rapid growth of a primary choroidal melanoma. Arch Ophthalmol Chic Ill 1960 101(9):1375–1377CrossRef Friberg TR, Fineberg E, McQuaig S (1983) Extremely rapid growth of a primary choroidal melanoma. Arch Ophthalmol Chic Ill 1960 101(9):1375–1377CrossRef
22.
Zurück zum Zitat Shields CL, Sioufi K, Srinivasan A et al (2018) Visual outcome and millimeter incremental risk of metastasis in 1780 patients with small choroidal melanoma managed by plaque radiotherapy. JAMA Ophthalmol 136(12):1325–1333CrossRefPubMedPubMedCentral Shields CL, Sioufi K, Srinivasan A et al (2018) Visual outcome and millimeter incremental risk of metastasis in 1780 patients with small choroidal melanoma managed by plaque radiotherapy. JAMA Ophthalmol 136(12):1325–1333CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kines RC, Varsavsky I, Choudhary S et al (2018) An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma. Mol Cancer Ther 17(2):565–574CrossRefPubMed Kines RC, Varsavsky I, Choudhary S et al (2018) An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma. Mol Cancer Ther 17(2):565–574CrossRefPubMed
Metadaten
Titel
Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis
verfasst von
Frances Wu
Anne Marie Lane
Monica M. Oxenreiter
Evangelos S. Gragoudas
Ivana K. Kim
Publikationsdatum
02.06.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 12/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-023-06130-0

Weitere Artikel der Ausgabe 12/2023

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.